2 recruiting, 1 withdrawn. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Recruiting 2, Withdrawn 1 |
Follow Common Bile Duct Diseases: new trials by email Literature Review of Common Bile Duct Diseases trials Research Report on Common Bile Duct Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Food-Effect, Single and Multiple Dose Pharmacokinetics, Safety and Tolerability Study of 4-MUST, 128 mg, Tablets in Healthy Volunteers 4-MUST - Chronic Cholecystitis, Biliary Dyskinesia | Phase 1 | Recruiting | Valenta Pharm JSC | 45 | 2026-01-26 | 2026-06-15 |
| Pharmacokinetics, Bioequivalence, and Safety Study of Trimedat® 76,95 mg Orally Disintegrating Tablets and Trimedat® 100 mg Tablets in Healthy Volunteers. Trimedat® - Irritable Bowel Syndrome, Gallstone Disease | Phase 1 | Recruiting | Valenta Pharm JSC | 36 | 2025-11-06 | 2026-02-19 |
| Transvaginal Cholecystectomy Using Endoscopic Assistance cholecystectomy. - Cholelithiasis, Cholecystitis | Phase 1 | Withdrawn | University of Missouri-Columbia | 2009-01-01 | 2016-09-30 |
Biliary Dyskinesia (3) · Cholelithiasis (2) · Cholecystitis (1) · Gastroesophageal Reflux (1) · Irritable Bowel Syndrome (1) · Postcholecystectomy Syndrome (1)
Bile Duct Diseases (3) · Biliary Tract Diseases (3) · Digestive System Diseases (3) · Colonic Diseases (1) · Colonic Diseases, Functional (1) · Deglutition Disorders (1) · Esophageal Diseases (1) · Esophageal Motility Disorders (1) · Gallbladder Diseases (1) · Gastrointestinal Diseases (1) · Intestinal Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Postoperative Complications (1)
Cholecystectomy (1) · Trimebutine (1)
Valenta Pharm JSC (2) · University of Missouri-Columbia (1)
Russia (2)